| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |